Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.35 |
| ▸ | USP2 | O75604 | 1/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
| ▸ | CASP1 | P29466 | 1/20 | 0.35 |
| ▸ | CASP7 | P55210 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 3/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.31 |
| ▸ | TP53 | P04637 | 2/20 | 0.31 |
| ▸ | NPC1 | O15118 | 2/20 | 0.31 |
| ▸ | RAB9A | P51151 | 2/20 | 0.31 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.31 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24796127 | 0.88 | GAA (0.38) | USP2MAPTSMN1; SMN2ALDH1A1TP53 | |
| SCHEMBL24796132 | 0.88 | GAA (0.38) | USP2MAPTSMN1; SMN2ALDH1A1TP53 | |
| SCHEMBL21383928 | 0.88 | GAA (0.38) | USP2MAPTSMN1; SMN2ALDH1A1TP53 | |
| SCHEMBL24796115 | 0.88 | GAA (0.38) | USP2MAPTSMN1; SMN2ALDH1A1TP53 | |
| SCHEMBL26746701 | 0.88 | KMT2A (0.33) | USP2MAPTSMN1; SMN2ALDH1A1TP53 | |
| SCHEMBL26747759 | 0.83 | ALDH1A1 (0.33) | MAPTSMN1; SMN2ALDH1A1TP53NPC1 | |
| SCHEMBL21389312 | 0.82 | ALDH1A1 (0.34) | HSD17B10USP2ALOX15CASP1CASP7 | |
| SCHEMBL21389449 | 0.82 | ALDH1A1 (0.34) | HSD17B10USP2ALOX15CASP1CASP7 | |
| SCHEMBL24796300 | 0.81 | CYP1A2 (0.40) | SMN1; SMN2ALDH1A1NPC1RAB9AKMT2A | |
| SCHEMBL21389308 | 0.78 | CYP2C19 (0.38) | HSD17B10USP2ALOX15CASP1CASP7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11535660-B1 | Modulators of G-protein coupled receptors | Cannot Therapeutics, Inc. (US) | 2022-12-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11535660-B1 | Modulators of G-protein coupled receptors | GIPR, GLP1R, GCGR | HSD17B10 3804/4885USP2 2718/4885ALOX15 4482/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.